GILD
Closed
Gilead Sciences Inc
111.73
+0.86 (+0.78%)
Last Update: 01 Jul 2025 23:26:00
Yesterday: 110.87
Day's Range: 110.8 - 112.565
Send
sign up or login to leave a comment!
When Written:
83.6799
Gilead Sciences Inc. is a biopharmaceutical company that develops and commercializes therapies for life-threatening diseases. The company was founded in 1987 and is headquartered in Foster City, California. Gilead Sciences is known for developing antiviral drugs for the treatment of HIV/AIDS, hepatitis B, and hepatitis C. The company's most successful drug is Sovaldi, which was approved by the FDA in 2013 for the treatment of hepatitis C. Gilead Sciences has also developed drugs for the treatment of cancer, respiratory diseases, and cardiovascular diseases. The company has operations in North America, Europe, and Asia, and has a workforce of over 12,000 employees worldwide.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








